Heedlesspage - can I ask why you think our P2 is a stronger study?
I am not medically minded but the abstract above suggests that 51 people were part of the trial, of which 97% showed clinically meaningful improvements.
Isn't "Clinically Meaningful" a better outcome than statistical significance?
Appreciate any insights you may have!
Angelman trial, page-64
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$14.96 |
Change
-0.170(1.12%) |
Mkt cap ! $1.912B | |||
| Open | High | Low | Value | Volume |
| $15.06 | $15.37 | $14.95 | $5.553M | 367.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 313 | $14.96 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $15.00 | 8746 | 3 |
View Market Depth
| Last trade - 16.10pm 02/10/2024 (20 minute delay) ? |
| NEU (ASX) Chart |